Dr Roopinder Gillmore received her first degree from the University of Cambridge and subsequently qualified as a doctor from Guy’s and St Thomas’ Medical School. She carried out her oncology training and has worked in various cancer hospitals including the Royal Marsden Hospital, the Hammersmith and Charing Cross hospitals, UCLH and the Royal Free Hospital.

She completed her PhD at Imperial College London under the supervision of Prof Hans Stauss. Her research focused on analysing immune responses in patients with solid cancers to determine processes by which patients’ immune responses develop an inability to recognise and kill cancer cells – with a view to developing immune-based treatments for cancer patients. 

She joined the Royal Free hospital as a consultant in 2009 and established the cancer of unknown primary Service (CUP) which received excellent feedback following national peer review.  The CUP service reviews all patients who have scans demonstrating evidence of metastatic cancer in the absence of a definite primary, the aim of the service is to help investigate patients appropriately ensuring this is carried out in a timely manner.  She continues to be the trust lead for the cancer of unknown primary service and chairs the weekly cancer of unknown primary multi-disciplinary meeting.

The Royal Free Hospital is the tertiary referral centre for pancreato-biliary cancers for North Central London and hosts the weekly specialist MDT.  As well as the CUP service, Dr Gillmore is the trust medical oncology lead for pancreas and biliary tract cancers and as such, attends the weekly pancreato-biliary multidisciplinary meeting.  She specialises in providing systemic anti-cancer treatments for these cancers. 

Dr Gillmore is a member of the North Central London expert reference groups for acute oncology and cancer of unknown primary, pancreato-biliary cancer as well the chemotherapy group.